Literature DB >> 7982732

Migratory activity of blood polymorphonuclear leukocytes during juvenile rheumatoid arthritis, demonstrated with a new whole-blood membrane filter assay.

G Egger1, C Klemt, S Spendel, W Kaulfersch, H Kenzian.   

Abstract

Polymorphonuclear leukocyte (PMN) migration is measured in whole blood in a migration chamber consisting of a membrane filter (3-microns pores, 140 microns thick) with an integrated chemoattractant depot (FMLP in solid form) attached to a plastic container. Control chambers lack FMLP (blanks). One test unit requires 300 microliters blood. Numbers and distribution of the PMN immigrants into the filters are determined microscopically. Altogether 26 measurements of PMN migration in five juvenile rheumatoid arthritis (JRA) patients with varying disease activity were compared with the reactions of a healthy control group (N = 32). Correlations were calculated with conventional laboratory parameters (WBC, PLT, BSR, CRP, Hgb, serum Fe) and disease activity. In comparison with healthy controls, PMNs of JRA patients generally show a markedly increased penetration depth into the filters irrespective the presence of the chemoattractant or the disease activity. Increased migratory reactions to FMLP in comparison to blanks were found during high disease activity only. The PMN penetration depth correlates positively with the CRP, and reciprocally with the Hgb blood levels. The migration assay combines fast and simple processing with good preservation of the genuine PMN activation state.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7982732     DOI: 10.1007/BF01534440

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  23 in total

Review 1.  Rheumatoid arthritis. Pathophysiology and implications for therapy.

Authors:  E D Harris
Journal:  N Engl J Med       Date:  1990-05-03       Impact factor: 91.245

2.  Cytokines and soluble interleukin 2 receptors in rheumatoid arthritis.

Authors:  R E Wolf; W G Brelsford; V C Hall; S B Adams
Journal:  J Rheumatol       Date:  1992-04       Impact factor: 4.666

3.  Effects of preparative technique on the rate of adoption of crawling-like movements by polymorphonuclear leukocytes.

Authors:  L P Bignold
Journal:  Cell Biol Int Rep       Date:  1987-01

4.  Neutrophil aggregation during migration in vivo.

Authors:  G Egger; S Porta; D Gollmann
Journal:  Inflammation       Date:  1982-06       Impact factor: 4.092

5.  Functions of polymorphonuclear leukocytes in early rheumatoid arthritis.

Authors:  M Leirisalo-Repo; L Paimela; S Koskimies; H Repo
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

6.  [The use of sustained-release preparations for eye-platelet diagnosis for noninvasive determination of leukocyte migration in the eye].

Authors:  W Korsatko; G Egger
Journal:  Pharmazie       Date:  1988-11       Impact factor: 1.267

7.  Neutrophil responsiveness to chemoattractant tripeptide in rheumatoid arthritis.

Authors:  R A Turner; J A Johnson; S R Turner
Journal:  Proc Soc Exp Biol Med       Date:  1987-11

Review 8.  Juvenile rheumatoid arthritis: outcome and treatment for the 1990s.

Authors:  C A Wallace; J E Levinson
Journal:  Rheum Dis Clin North Am       Date:  1991-11       Impact factor: 2.670

9.  Priming of human neutrophil functions by tumor necrosis factor: enhancement of superoxide anion generation, degranulation, and chemotaxis to chemoattractants C5a and F-Met-Leu-Phe.

Authors:  M S Bajaj; R R Kew; R O Webster; T M Hyers
Journal:  Inflammation       Date:  1992-06       Impact factor: 4.092

Review 10.  Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritis.

Authors:  M Feldmann; F M Brennan; R O Williams; A P Cope; D L Gibbons; P D Katsikis; R N Maini
Journal:  Prog Growth Factor Res       Date:  1992
View more
  9 in total

1.  Blood polymorphonuclear leukocyte activation in atherosclerosis: effects of aspirin.

Authors:  G Egger; A Burda; A Obernosterer; H Mitterhammer; G Kager; G Jürgens; H P Hofer; J S Fabjan; E Pilger
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

2.  The influence of trauma on changes in neutrophil granulocyte function assessed by an analysis of granulocyte migration.

Authors:  H P Hofer; G Egger; E M Kukovetz; G Bratschitsch; P Steindorfer; R J Schaur
Journal:  Langenbecks Arch Chir       Date:  1996

3.  Blood polymorphonuclear leukocyte migration as a predictive marker for infections in severe trauma: comparison with various inflammation parameters.

Authors:  Gerd Egger; Reingard Aigner; Andreas Glasner; Herwig P Hofer; Heike Mitterhammer; Sieglinde Zelzer
Journal:  Intensive Care Med       Date:  2004-01-16       Impact factor: 17.440

4.  Blood polymorphonuclear leukocyte migratory activities during rheumatoid arthritis.

Authors:  G Egger; F Aglas; F Rainer
Journal:  Inflammation       Date:  1995-12       Impact factor: 4.092

5.  Impaired whole-blood polymorphonuclear leukocyte migration as a possible predictive marker for infections in preterm premature rupture of membranes.

Authors:  A Glasner; G Egger; R Winter
Journal:  Infect Dis Obstet Gynecol       Date:  2001

6.  Neutrophils: the forgotten cell in JIA disease pathogenesis.

Authors:  James N Jarvis; Kaiyu Jiang; Howard R Petty; Michael Centola
Journal:  Pediatr Rheumatol Online J       Date:  2007-06-13       Impact factor: 3.054

7.  Novel approaches to gene expression analysis of active polyarticular juvenile rheumatoid arthritis.

Authors:  James N Jarvis; Igor Dozmorov; Kaiyu Jiang; Mark Barton Frank; Peter Szodoray; Philip Alex; Michael Centola
Journal:  Arthritis Res Ther       Date:  2003-11-06       Impact factor: 5.156

8.  Abnormal directed migration of blood polymorphonuclear leukocytes in rheumatoid arthritis. Potential role in increased susceptibility to bacterial infections.

Authors:  F Aglas; J Hermann; G Egger
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

9.  Modeling Transcriptional Rewiring in Neutrophils Through the Course of Treated Juvenile Idiopathic Arthritis.

Authors:  Zihua Hu; Kaiyu Jiang; Mark Barton Frank; Yanmin Chen; James N Jarvis
Journal:  Sci Rep       Date:  2018-05-17       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.